Patents by Inventor David W. Stroman

David W. Stroman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9993483
    Abstract: The present invention relates to methods for treating an ophthalmic, otic, or nasal infection comprising treating the infected tissue with a composition comprising finafloxacin or a finafloxacin derivative. The present invention also relates to antimicrobial compositions comprising finafloxacin or a finafloxacin derivative. The compositions are suitable for the treatment of ophthalmic, otic, or nasal infections.
    Type: Grant
    Filed: July 27, 2015
    Date of Patent: June 12, 2018
    Assignee: Alcon Research, Ltd.
    Inventors: David W. Stroman, Masood A. Chowhan, Kenneth C. Appell
  • Publication number: 20150328229
    Abstract: The present invention relates to methods for treating an ophthalmic, otic, or nasal infection comprising treating the infected tissue with a composition comprising finafloxacin or a finafloxacin derivative. The present invention also relates to antimicrobial compositions comprising finafloxacin or a finafloxacin derivative. The compositions are suitable for the treatment of ophthalmic, otic, or nasal infections.
    Type: Application
    Filed: July 27, 2015
    Publication date: November 19, 2015
    Inventors: David W. Stroman, Masood A. Chowhan, Kenneth C. Appell
  • Patent number: 9119859
    Abstract: The present invention relates to methods for treating an ophthalmic, otic, or nasal infection comprising treating the infected tissue with a composition comprising finafloxacin or a finafloxacin derivative. The present invention also relates to antimicrobial compositions comprising finafloxacin or a finafloxacin derivative. The compositions are suitable for the treatment of ophthalmic, otic, or nasal infections.
    Type: Grant
    Filed: August 15, 2013
    Date of Patent: September 1, 2015
    Assignee: Alcon Research, Ltd.
    Inventors: David W. Stroman, Masood A. Chowhan, Kenneth C. Appell
  • Patent number: 8993636
    Abstract: Ophthalmic, otic and nasal compositions containing a new class of antibiotics (e.g., moxifloxacin) are disclosed. The compositions preferably also contain one or more anti-inflammatory agents. The compositions may be utilized to treat ophthalmic, otic and nasal conditions by topically applying the compositions to the affected tissues.
    Type: Grant
    Filed: October 25, 2013
    Date of Patent: March 31, 2015
    Assignee: Alcon Pharamceuticals, Ltd.
    Inventors: Gerald Cagle, Robert L. Abshire, David W. Stroman, John M. Yanni
  • Patent number: 8673902
    Abstract: Ophthalmic, otic and nasal compositions containing a new class of antibiotics (e.g., moxifloxacin) are disclosed. The compositions preferably also contain one or more anti-inflammatory agents. The compositions may be utilized to treat ophthalmic, otic and nasal conditions by topically applying the compositions to the affected tissues.
    Type: Grant
    Filed: November 3, 2009
    Date of Patent: March 18, 2014
    Assignee: Alcon Pharmaceuticals, Ltd.
    Inventors: Gerald Cagle, Robert L. Abshire, David W. Stroman, John M. Yanni
  • Publication number: 20140051670
    Abstract: Ophthalmic, otic and nasal compositions containing a new class of antibiotics (e.g., moxifloxacin) are disclosed. The compositions preferably also contain one or more anti-inflammatory agents. The compositions may be utilized to treat ophthalmic, otic and nasal conditions by topically applying the compositions to the affected tissues.
    Type: Application
    Filed: October 25, 2013
    Publication date: February 20, 2014
    Inventors: Gerald Cagle, Robert L. Abshire, David W. Stroman, John M. Yanni
  • Publication number: 20130331385
    Abstract: The present invention relates to methods for treating an ophthalmic, otic, or nasal infection comprising treating the infected tissue with a composition comprising finafloxacin or a finafloxacin derivative. The present invention also relates to antimicrobial compositions comprising finafloxacin or a finafloxacin derivative. The compositions are suitable for the treatment of ophthalmic, otic, or nasal infections.
    Type: Application
    Filed: August 15, 2013
    Publication date: December 12, 2013
    Applicant: Alcon Research, Ltd.
    Inventors: David W. Stroman, Masood A. Chowhan, Kenneth C. Appell
  • Patent number: 8536167
    Abstract: The present invention relates to methods for treating an ophthalmic, otic, or nasal infection comprising treating the infected tissue with a composition comprising finafloxacin or a finafloxacin derivative. The present invention also relates to antimicrobial compositions comprising finafloxacin or a finafloxacin derivative. The compositions are suitable for the treatment of ophthalmic, otic, or nasal infections.
    Type: Grant
    Filed: July 2, 2010
    Date of Patent: September 17, 2013
    Assignee: Alcon Research, Ltd.
    Inventors: David W. Stroman, Masood A. Chowhan, Kenneth C. Appell
  • Publication number: 20120108557
    Abstract: The present invention relates to fluoroquinolone derivatives having enhanced ocular penetration characteristics and/or antimicrobial activity, and to compositions comprising such derivatives. The derivatives and compositions are particularly well suited for treating ophthalmic bacterial infections. The present invention more particularly relates to the discovery that a 2-methyl substitution on a diazabicyclo group attached to a fluoroquinolone ring system produces improved permeability characteristics, and that a 5-amino substitution on a fluoroquinolone ring system results in improved anti-microbial activity.
    Type: Application
    Filed: January 13, 2012
    Publication date: May 3, 2012
    Applicant: ALCON RESEARCH, LTD.
    Inventors: Geoffrey Robert Owen, Amy C. Brooks, Lina F. Bernal-Perez, David W. Stroman, Joseph J. Dajcs
  • Publication number: 20110160172
    Abstract: The present invention relates to fluoroquinolone derivatives having enhanced ocular penetration characteristics and/or antimicrobial activity, and to compositions comprising such derivatives. The derivatives and compositions are particularly well suited for treating ophthalmic bacterial infections. The present invention more particularly relates to the discovery that a 2-methyl substitution on a diazabicyclo group attached to a fluoroquinolone ring system produces improved permeability characteristics, and that a 5-amino substitution on a fluoroquinolone ring system results in improved anti-microbial activity.
    Type: Application
    Filed: March 8, 2011
    Publication date: June 30, 2011
    Applicant: ALCON RESEARCH, LTD.
    Inventors: Geoffrey Robert Owen, Amy C. Brooks, Lina Bernal-Perez, David W. Stroman, Joseph J. Dajcs
  • Publication number: 20110124734
    Abstract: The present invention relates to methods for disinfecting or cleaning a contact lens comprising contacting a contact lens with a formulation comprising a N-halogenated amino acid and a phase transfer agent for a time sufficient to disinfect or clean the lens. This specification further discloses a formulation for disinfecting a contact lens comprising an N-halogenated amino acid and a phase transfer agent.
    Type: Application
    Filed: January 31, 2011
    Publication date: May 26, 2011
    Applicant: ALCON RESEARCH, LTD.
    Inventors: Masood A. Chowhan, Wesley Wehsin Han, L. Wayne Schneider, David W. Stroman, Nissanke L. Dassanayake
  • Publication number: 20110071116
    Abstract: The present invention relates to a formulation comprising a N-halogenated amino acid and a phase transfer agent. The present invention also describes a method for disinfecting and/or cleaning a contact lens comprising contacting a contact lens with a formulation comprising a N-halogenated amino acid salt for a time sufficient to disinfect and/or clean the lens.
    Type: Application
    Filed: November 24, 2010
    Publication date: March 24, 2011
    Applicant: ALCON RESEARCH, LTD.
    Inventors: L. Wayne Schneider, Wesley Wehsin Han, Masood A. Chowhan, David W. Stroman, W. Dennis Dean, Michael S. Gaines
  • Publication number: 20110060044
    Abstract: The present invention relates to methods for treating an infected tissue comprising treating the infected tissue with a formulation comprising a N-halogenated amino acid and an aliphatic acid. This specification also discloses methods for improving the antimicrobial activity of a formulation comprising a N-halogenated amino acid, the method comprising adding an aliphatic acid to said formulation.
    Type: Application
    Filed: November 16, 2010
    Publication date: March 10, 2011
    Applicant: ALCON RESEARCH, LTD.
    Inventors: Masood A. Chowhan, Wesley Weshin Han, Wayne L. Schneider, David W. Stroman
  • Publication number: 20110003803
    Abstract: The present invention relates to methods for treating an ophthalmic, otic, or nasal infection comprising treating the infected tissue with a composition comprising finafloxacin or a finafloxacin derivative. The present invention also relates to antimicrobial compositions comprising finafloxacin or a finafloxacin derivative. The compositions are suitable for the treatment of ophthalmic, otic, or nasal infections.
    Type: Application
    Filed: July 2, 2010
    Publication date: January 6, 2011
    Applicant: ALCON RESEARCH, LTD.
    Inventors: David W. Stroman, Masood A. Chowhan, Kenneth C. Appell
  • Publication number: 20100204181
    Abstract: The present invention relates to methods for treating an infected tissue comprising treating the infected tissue with a formulation comprising a N-halogenated amino acid and a phosphine oxide or amine oxide. This specification also discloses methods for improving the antimicrobial activity of a formulation comprising a N-halogenated amino acid, the method comprising adding a phosphine oxide or amine oxide to said formulation.
    Type: Application
    Filed: February 5, 2010
    Publication date: August 12, 2010
    Applicant: ALCON RESEARCH, LTD.
    Inventors: David W. STROMAN, Masood A. CHOWHAN, Wayne L. SCHNEIDER, John Greg BARTELL, Wesley Wehsin HAN
  • Patent number: 7671070
    Abstract: Ophthalmic, otic and nasal compositions containing a new class of antibiotics (e.g., moxifloxacin) are disclosed. The compositions preferably also contain one or more anti-inflammatory agents. The compositions may be utilized to treat ophthalmic, otic and nasal conditions by topically applying the compositions to the affected tissues.
    Type: Grant
    Filed: November 17, 2003
    Date of Patent: March 2, 2010
    Assignee: Alcon, Inc.
    Inventors: Gerald Cagle, Robert L. Abshire, David W. Stroman, John M. Yanni
  • Publication number: 20100048522
    Abstract: Ophthalmic, otic and nasal compositions containing a new class of antibiotics (e.g., moxifloxacin) are disclosed. The compositions preferably also contain one or more anti-inflammatory agents. The compositions may be utilized to treat ophthalmic, otic and nasal conditions by topically applying the compositions to the affected tissues.
    Type: Application
    Filed: November 3, 2009
    Publication date: February 25, 2010
    Applicant: ALCON, INC.
    Inventors: Gerald Cagle, Robert L. Abshire, David W. Stroman, John M. Yanni
  • Publication number: 20090209574
    Abstract: The present invention relates to fluoroquinolone derivatives having enhanced ocular penetration characteristics and/or antimicrobial activity, and to compositions comprising such derivatives. The derivatives and compositions are particularly well suited for treating ophthalmic bacterial infections. The present invention more particularly relates to the discovery that a 2-methyl substitution on a diazabicyclo group attached to a fluoroquinolone ring system produces improved permeability characteristics, and that a 5-amino substitution on a fluoroquinolone ring system results in improved anti-microbial activity.
    Type: Application
    Filed: February 16, 2009
    Publication date: August 20, 2009
    Applicant: ALCON RESEARCH, LTD.
    Inventors: Geoffrey Robert Owen, Amy C. Brooks, Lina Bernal-Perez, David W. Stroman, Joseph J. Dajcs
  • Publication number: 20090197838
    Abstract: The present invention relates to a formulation comprising a N-halogenated amino acid and a phase transfer agent. The present invention also describes a method for disinfecting and/or cleaning a contact lens comprising contacting a contact lens with a formulation comprising a N-halogenated amino acid salt for a time sufficient to disinfect and/or clean the lens.
    Type: Application
    Filed: April 30, 2008
    Publication date: August 6, 2009
    Applicant: ALCON RESEARCH, LTD.
    Inventors: L. Wayne Schneider, Wesley Wehsin Han, Masood A. Chowhan, David W. Stroman, W. Dennis Dean, Michael S. Gaines
  • Publication number: 20080275123
    Abstract: The present invention relates to a method for treating a tissue infection comprising contacting the infected tissue with a pharmaceutically effective amount of a formulation comprising a N-halogenated amino acid and a phase transfer agent. This specification also describes a formulation having antimicrobial activity comprising a N-halogenated amino acid and a phase transfer agent.
    Type: Application
    Filed: April 30, 2008
    Publication date: November 6, 2008
    Applicant: ALCON RESEARCH, LTD.
    Inventors: Masood A. Chowhan, Nissanke L. Dassanayake, Wesley Wehsin Han, Wayne L. Schneider, David W. Stroman